Damian J. Green

Also affiliated with University of Washington, Fred Hutch Cancer Center, Sylvester Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy”.

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.04.001

N/A

3.7DataRank · unranked

144 citations

Emily C. Liang, Qian Wu, Jenna Voutsinas, Pere Barba, Gloria Iacoboni +19 more

γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00246-2

N/A

2.5DataRank · unranked

101 citations

Margot J. Pont, Blythe Sather, Cameron J. Turtle, Brian G. Till, Edward N. Libby +15 more

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023011287

N/A

1.7DataRank · unranked

55 citations

Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna Voutsinas +18 more

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Blood(2021)10.1182/blood.2020006770

N/A

0.807DataRank · unranked

216 citations

Evandro D. Bezerra, Alexandre V. Hirayama, Salvatore Fiorenza, Alyssa Sheih, Cassie K. Chou +20 more

Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy

medRxiv(2023)10.1101/2023.12.19.23300188

N/A

0.637DataRank · unranked

7 citations

David Yu, Alysa Rallistan, Müge Kalaycıoğlu, Jim Boonyaratanakornkit, Damian J. Green +28 more

Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

Clinical Infectious Diseases(2023)10.1093/cid/ciad708

N/A

0.596DataRank · unranked

52 citations

Sarah Ibrahimi, Hu Xie, Elizabeth R Wong, Jessica Hecht, Mandeep K Sekhon +11 more

Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy

American Journal of Transplantation(2023)10.1016/j.ajt.2022.11.001

N/A

0.477DataRank · unranked

23 citations

Erika S. Kiem, Atif Bhatti, Winnie Liu, Jacob Keane-Candib, Kristin Fitzpatrick +10 more

Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients

Blood(2024)10.1182/blood.2024024145

N/A

0.449DataRank · unranked

19 citations

Elizabeth M. Krantz, Hu Xie, Sarah Ibrahimi, Erika S. Kiem, Mandeep K Sekhon +13 more

A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma

American Journal of Hematology(2020)10.1002/ajh.25818

N/A

0.360DataRank · unranked

10 citations

Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Ryan D. Cassaday, Paul S. Martin +8 more

Development and validation of predictive models of early immune effector cell–associated hematotoxicity

Blood Advances(2024)10.1182/bloodadvances.2024014455

N/A

0.360DataRank · unranked

10 citations

Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz‐Maldonado, Aya Albittar, Natalie Wuliji +28 more

CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.17.628799

N/A

0.165DataRank · unranked

2 citations

Linda B. Baughn, Mansour Poorebrahim, Alexandra M. Poos, Holly Lee, Marcella Kaddoura +24 more

High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma

JCO Precision Oncology(2021)10.1200/po.20.00442

N/A

0DataRank · unranked

16 citations

Andrew J. Cowan, Bret DeGraaff, Timothy J. Martins, Niall Curley, Damian J. Green +9 more

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma

Nature Communications(2023)10.1038/s41467-023-40966-8

N/A

0DataRank · unranked

39 citations

Francesco Maura, Edgar Gonzalez‐Kozlova, J. Javier Díaz-Mejía, Ping Luo, Yong Zhang +18 more

CD8+ chimeric antigen receptor T cells manufactured in absence of CD4+ cells exhibit hypofunctional phenotype

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007803

N/A

0DataRank · unranked

36 citations

Dong Hoon Lee, Wei Sun, Francisco Cervantes-Contreras, Ryan Basom, Feinan Wu +8 more

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003428

N/A

0DataRank · unranked

45 citations

Andrea N. Loes, Kiel Shuey, Elizabeth M. Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib +13 more

Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies

JCI Insight(2021)10.1172/jci.insight.146743

N/A

0DataRank · unranked

62 citations

Elizabeth M. Krantz, Joyce Maalouf, Jim Boonyaratanakornkit, Jacob Keane-Candib, Laurel Joncas-Schronce +13 more

TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

Science Immunology(2024)10.1126/sciimmunol.adg1094

N/A

0DataRank · unranked

50 citations

Olivia G. Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S. Ensbey +16 more

Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunity

Journal of Clinical Investigation(2024)10.1172/jci180012

N/A

0DataRank · unranked

44 citations

David Yu, Alysa Rallistan, Müge Kalaycıoğlu, Jim Boonyaratanakornkit, Damian J. Green +29 more

Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy

Blood(2024)10.1182/blood.2024025231

N/A

0DataRank · unranked

15 citations

Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J. Cowan, Sylvain Simon +6 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

UNC Libraries(2020)10.17615/w76e-ms81

N/A

0DataRank · unranked

0 citations

Amanda Axtman, Mark D. Hylarides, Jaideep Shenoi, Shani M. Frayo, Steven I. Park +11 more

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy

Blood Advances(2025)10.1182/bloodadvances.2024015164

N/A

0DataRank · unranked

5 citations

Patrick W Flaherty, Hu Xie, Mandeep K Sekhon, Clementine Chalal, Terry Stevens‐Ayers +9 more

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy

medRxiv(2021)10.1101/2021.05.10.21256634

N/A

0DataRank · unranked

7 citations

Andrea N. Loes, Kiel Shuey, Elizabeth M. Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib +13 more

Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.005

N/A

0DataRank · unranked

42 citations

Margot J. Pont, Sayan Dasgupta, Xiaoling Song, Sushma Thomas, Gregory Pepper +10 more